Combaillaux, France

Vincent Santucci


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Combaillaux, FR (1993 - 1994)
  • Montpellier, FR (1998)

Company Filing History:


Years Active: 1993-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Vincent Santucci: Innovator in Cardio-Regulatory Pharmaceuticals

Introduction

Vincent Santucci is a notable inventor based in Combaillaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs aimed at regulating cardiovascular functions. With a total of three patents to his name, Santucci's work has the potential to impact the treatment of heart-related disorders.

Latest Patents

One of Santucci's latest patents is focused on the use of NK.sub.1 receptor antagonists for preparing cardio-regulatory drugs. This invention is particularly relevant for controlling heart rate disorders and cardiac dysrhythmia. Another significant patent involves hexahydroazepine derivatives, detailing a process for their preparation. These derivatives are characterized by specific chemical structures that may offer new avenues for therapeutic applications.

Career Highlights

Throughout his career, Vincent Santucci has worked with prominent companies in the pharmaceutical industry, including Sanofi and Elf Sanofi. His experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities in drug development.

Collaborations

Santucci has collaborated with notable professionals in his field, including Serge Lavastre and Jean-Pierre Maignan. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Vincent Santucci stands out as an influential inventor in the realm of cardio-regulatory pharmaceuticals. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…